Navigation Links
Cryoablation: A New Treatment Option for Some Kidney Tumor Patients

Mayo Clinic researchers report that freezing kidney tumors through percutaneous cryoablation shows promise for patients who are not good candidates// for surgery. Their early findings showing short-term success in more than 90 percent of selected patients are published in this month’s issue of Radiology.

The standard treatment for kidney tumors is surgery, providing a high likelihood of a long-term cure. For some patients, surgery is not an option, and Mayo’s urologists and radiologists collaborated to find alternatives for these individuals. If these patients are frail due to age or illness or are not able to have surgery because of other factors, percutaneous cryoablation may be an option.

“This procedure appears to be a good option for some patients,” says Thomas Atwell, M.D., Mayo Clinic radiologist and the study’s primary investigator. “It makes their hospital stay and recovery time very short and surgical stress is minimal.” He cautions that this procedure is not ideal for everyone, noting that it is an option for only a relatively small subset of patients.

Percutaneous ablation uses needles to penetrate the skin and deliver directly to the tumor either high-intensity, tissue-destroying heat through radiofrequency ablation, or freezing cold through cryoablation. Mayo Clinic’s radiologists are among the most experienced in the world in performing ablation techniques, and have treated nearly 300 kidney tumors either with radiofrequency ablation or cryoablation. Radiofrequency ablation (RFA) burns away the tumor, while cryoablation freezes it.

Mayo Clinic doctors had previous experience with liver tumor cryoablation when they added kidney tumor cryoablation in 2003. Today’s report contains the largest published results for percutaneous cryoablation patients. Mayo researchers report that not only can this technique be an alternative to surgery, but that in some cases, it has benefits over RFA.

Previous ex
'"/>




Page: 1 2 3

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
(Date:12/2/2008)... form an integral part of most of,original equipm...ore become,essential for service providers in the...in competitive and constantly improve their servic...: http://www.newscom.com/cgi-bin/prnh/20081117/F...livan ( http://www.medicalimaging.frost.com ),Eur...
(Date:12/2/2008)...ctation Service, one of the premier leaders in med...egal dictation transcription, has joined up with ...organization geared to the betterment of women and...ughout Lower Westchester County, New York. , ..., 2008 -- World Wide Dictation Services of New Yor...
(Date:12/2/2008)...s ASHP midyear meeting, FFF Enterprises, the natio...al-care biopharmaceuticals and vaccines, will unve...rity and demonstrate how the company has taken pha...439) , (Vocus) December 2... Enterprises, the nation,s largest and most truste...
(Date:12/2/2008)...lies, the problem with the holidays is family. El...how caregivers of aging parents can bring the joy .... , San Mateo, CA (PRWEB)...of the holiday season is family, especially aging ...her Koch , founder of Encore Management , has a s...
Breaking Medicine News(10 mins):Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:World Wide Dictation Service Teams up with TMATT for Local Thanksgiving Community Dinner 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 3Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 2Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 3
...ctions are both of great public health importance ...gues have found that acute malaria episodes are as...oad in the blood,// and they speculate that malari...ase progression and facilitate transmission. Evid...
...ed today at the 47th Annual Meeting of the America...n Denver, Colorado say that there is no direct lin...he aggressiveness of prostate cancer, but the long...ers at Fox Chase Cancer Center found no correlatio...
...has been conducted to understand how the sexes dif...n differ in their inflammatory reactions to work-r..., different strategies would have to be devised to... It has also been shown that work-related burnout ...
...tree like, diffuse articular lipomatosis) is a rar...ogy. //It is a very rare primary benign tumour of ...iagnosis for a slowly progressive chronically swol...rescens have previously been reported, usually inv...
Other Medicine News:Health News:Malaria infection can accelerate HIV infection and disease progression 2Health News:Sexes differ in response to burnout on the job and depression 2Health News:Lipoma Arborescens: A Rare Tumor Of The Knee 2
(Date:12/1/2008)...EGO, Dec. 1 Vical Incorp...pt of a $1.0 million milestone payment from Merck ...n of a Phase I clinical trial of an investigationa... vaccine is based on Vical,s DNA gene delivery tec...criptase (hTERT). hTERT is the subject of separate...
(Date:11/27/2008)...udy finds the majority of acute lymphoblastic leuk...nt at the time of diagnosis , , MEMPHIS, Te... at St. Jude Children,s Research Hospital have ide...cells of children with acute lymphoblastic leukemi...athway to designing treatments for ALL relapse in ...
(Date:11/25/2008)...ILLE, Ky., Nov. 25 Klei...eons performed the fifth U.S. hand transplant on M... Louisville,s Jewish Hospital Hand Care Center on ...an around noon and was completed shortly after 9 p...ttp://www.newscom.com/cgi-bin/prnh/20081125/DC4855...
(Date:11/25/2008)...tients Enrolled in Clinical Trial to Assess Surviv...are Therapies for Unresectable Hepatocellular Carc...ire/ -- Light Sciences Oncology, Inc. (LSO) today ... Phase 3 clinical trial of Light Infusion Therapy(...atocellular carcinoma (HCC), also known as hepatom...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Dynatronics Announces 24250 000 Increase in Stock Buyback Program 7510 1Dynatronics Announces 24250 000 Increase in Stock Buyback Program 7510 2In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 1In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 2In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 3In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 4In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 5In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 6Exercising our immune system 7500 1Exercising our immune system 7500 23 Common Drugs Trigger Most ER Visits by Seniors 7496 13 Common Drugs Trigger Most ER Visits by Seniors 7496 2
...re-FirstCall/ Haemacure,Corporation , a Montreal-b...unced the preliminary findings of the content anal...findings confirm the presence of a number of,prote...orldwide,markets, including albumin, plasminogen, ...a strategic significance for Haemacure as,revenues...
...-FirstCall/ --,Bristol-Myers Squibb Company today ...y of ORENCIA(R) (abatacept) from the open-label,ph...n with juvenile,idiopathic arthritis (JIA) who hav...e-modifying anti- rheumatic drugs (DMARDs), such,a...) antagonists.,The results demonstrated that, afte...
Other Medicine Technology:Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 2Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 3Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6
Solid 8 mm blades. Dull finish. Most popular size or model.
Open 10 mm blades. Dull finish.
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model.
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish.
Medicine Products: